ArticleJCI insight2023

First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival.

Maria V Guijarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.